ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Voriconazole Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-2L18355
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Oral Voriconazole Market Research Report 2024
BUY CHAPTERS

Global Oral Voriconazole Market Research Report 2024

Code: QYRE-Auto-2L18355
Report
September 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Sandoz Inc
Sun Pharmaceutical
TEVA
Taj Pharmaceuticals
SiNi Pharma
Lupin Pharmaceuticals
Viona Pharmaceuticals
Yangzijiang Pharmaceutical Group
Huahai Pharmaceutical
Brilliant Pharmaceuticals
Zhuhai Rundu Pharmaceutical
Poly Pharm
Beijing Genetech Pharmaceutical
Union-Bio science

Oral Voriconazole Market

Oral voriconazole is an antifungal drug taken by oral route. Voriconazole is used to treat serious fungal or yeast infections, such as aspergillosis (fungal infection in the lungs), candidemia (fungal infection in the blood), esophageal candidiasis (candida esophagitis), or other fungal infections (infections in the skin, stomach, kidney, bladder, or wounds). It may also be used to treat patients with serious fungal or yeast infections who cannot tolerate or do not respond to other types of treatment.
The global Oral Voriconazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Oral Voriconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Voriconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral Voriconazole in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral Voriconazole include Pfizer, Sandoz, Sun Pharmaceutical, Teva, Taj Pharmaceuticals, SiNi Pharma, Lupin Pharmaceuticals, Viona Pharmaceuticals, Yangzijiang Pharmaceutical Group, Huahai Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Voriconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Voriconazole.
The Oral Voriconazole market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Voriconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Voriconazole companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oral Voriconazole Market Report

Report Metric Details
Report Name Oral Voriconazole Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Sandoz, Sun Pharmaceutical, Teva, Taj Pharmaceuticals, SiNi Pharma, Lupin Pharmaceuticals, Viona Pharmaceuticals, Yangzijiang Pharmaceutical Group, Huahai Pharmaceutical, Beijing Genetech Pharmaceutical, Union-Bio science, Brilliant Pharmaceuticals, Zhuhai Rundu Pharmaceutical, Poly Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oral Voriconazole company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Voriconazole Market report?

Ans: The main players in the Oral Voriconazole Market are Pfizer, Sandoz, Sun Pharmaceutical, Teva, Taj Pharmaceuticals, SiNi Pharma, Lupin Pharmaceuticals, Viona Pharmaceuticals, Yangzijiang Pharmaceutical Group, Huahai Pharmaceutical, Beijing Genetech Pharmaceutical, Union-Bio science, Brilliant Pharmaceuticals, Zhuhai Rundu Pharmaceutical, Poly Pharm

What are the Application segmentation covered in the Oral Voriconazole Market report?

Ans: The Applications covered in the Oral Voriconazole Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Oral Voriconazole Market report?

Ans: The Types covered in the Oral Voriconazole Market report are Voriconazole Tablets, Voriconazole Capsules, Voriconazole Suspension

Recommended Reports

Fungal Infection Treatments

Oral Drug Therapies

Antifungal APIs & Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Voriconazole Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Voriconazole Tablets
1.2.3 Voriconazole Capsules
1.2.4 Voriconazole Suspension
1.3 Market by Application
1.3.1 Global Oral Voriconazole Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Voriconazole Market Perspective (2019-2030)
2.2 Global Oral Voriconazole Growth Trends by Region
2.2.1 Global Oral Voriconazole Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Voriconazole Historic Market Size by Region (2019-2024)
2.2.3 Oral Voriconazole Forecasted Market Size by Region (2025-2030)
2.3 Oral Voriconazole Market Dynamics
2.3.1 Oral Voriconazole Industry Trends
2.3.2 Oral Voriconazole Market Drivers
2.3.3 Oral Voriconazole Market Challenges
2.3.4 Oral Voriconazole Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Voriconazole Players by Revenue
3.1.1 Global Top Oral Voriconazole Players by Revenue (2019-2024)
3.1.2 Global Oral Voriconazole Revenue Market Share by Players (2019-2024)
3.2 Global Oral Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Voriconazole Revenue
3.4 Global Oral Voriconazole Market Concentration Ratio
3.4.1 Global Oral Voriconazole Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Voriconazole Revenue in 2023
3.5 Global Key Players of Oral Voriconazole Head office and Area Served
3.6 Global Key Players of Oral Voriconazole, Product and Application
3.7 Global Key Players of Oral Voriconazole, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Voriconazole Breakdown Data by Type
4.1 Global Oral Voriconazole Historic Market Size by Type (2019-2024)
4.2 Global Oral Voriconazole Forecasted Market Size by Type (2025-2030)
5 Oral Voriconazole Breakdown Data by Application
5.1 Global Oral Voriconazole Historic Market Size by Application (2019-2024)
5.2 Global Oral Voriconazole Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Voriconazole Market Size (2019-2030)
6.2 North America Oral Voriconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Voriconazole Market Size by Country (2019-2024)
6.4 North America Oral Voriconazole Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Voriconazole Market Size (2019-2030)
7.2 Europe Oral Voriconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Voriconazole Market Size by Country (2019-2024)
7.4 Europe Oral Voriconazole Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Voriconazole Market Size (2019-2030)
8.2 Asia-Pacific Oral Voriconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Voriconazole Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Voriconazole Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Voriconazole Market Size (2019-2030)
9.2 Latin America Oral Voriconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Voriconazole Market Size by Country (2019-2024)
9.4 Latin America Oral Voriconazole Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Voriconazole Market Size (2019-2030)
10.2 Middle East & Africa Oral Voriconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Voriconazole Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Voriconazole Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Voriconazole Introduction
11.1.4 Pfizer Revenue in Oral Voriconazole Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Sandoz
11.2.1 Sandoz Company Details
11.2.2 Sandoz Business Overview
11.2.3 Sandoz Oral Voriconazole Introduction
11.2.4 Sandoz Revenue in Oral Voriconazole Business (2019-2024)
11.2.5 Sandoz Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Oral Voriconazole Introduction
11.3.4 Sun Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Oral Voriconazole Introduction
11.4.4 Teva Revenue in Oral Voriconazole Business (2019-2024)
11.4.5 Teva Recent Development
11.5 Taj Pharmaceuticals
11.5.1 Taj Pharmaceuticals Company Details
11.5.2 Taj Pharmaceuticals Business Overview
11.5.3 Taj Pharmaceuticals Oral Voriconazole Introduction
11.5.4 Taj Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
11.5.5 Taj Pharmaceuticals Recent Development
11.6 SiNi Pharma
11.6.1 SiNi Pharma Company Details
11.6.2 SiNi Pharma Business Overview
11.6.3 SiNi Pharma Oral Voriconazole Introduction
11.6.4 SiNi Pharma Revenue in Oral Voriconazole Business (2019-2024)
11.6.5 SiNi Pharma Recent Development
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Company Details
11.7.2 Lupin Pharmaceuticals Business Overview
11.7.3 Lupin Pharmaceuticals Oral Voriconazole Introduction
11.7.4 Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
11.7.5 Lupin Pharmaceuticals Recent Development
11.8 Viona Pharmaceuticals
11.8.1 Viona Pharmaceuticals Company Details
11.8.2 Viona Pharmaceuticals Business Overview
11.8.3 Viona Pharmaceuticals Oral Voriconazole Introduction
11.8.4 Viona Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
11.8.5 Viona Pharmaceuticals Recent Development
11.9 Yangzijiang Pharmaceutical Group
11.9.1 Yangzijiang Pharmaceutical Group Company Details
11.9.2 Yangzijiang Pharmaceutical Group Business Overview
11.9.3 Yangzijiang Pharmaceutical Group Oral Voriconazole Introduction
11.9.4 Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (2019-2024)
11.9.5 Yangzijiang Pharmaceutical Group Recent Development
11.10 Huahai Pharmaceutical
11.10.1 Huahai Pharmaceutical Company Details
11.10.2 Huahai Pharmaceutical Business Overview
11.10.3 Huahai Pharmaceutical Oral Voriconazole Introduction
11.10.4 Huahai Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
11.10.5 Huahai Pharmaceutical Recent Development
11.11 Beijing Genetech Pharmaceutical
11.11.1 Beijing Genetech Pharmaceutical Company Details
11.11.2 Beijing Genetech Pharmaceutical Business Overview
11.11.3 Beijing Genetech Pharmaceutical Oral Voriconazole Introduction
11.11.4 Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
11.11.5 Beijing Genetech Pharmaceutical Recent Development
11.12 Union-Bio science
11.12.1 Union-Bio science Company Details
11.12.2 Union-Bio science Business Overview
11.12.3 Union-Bio science Oral Voriconazole Introduction
11.12.4 Union-Bio science Revenue in Oral Voriconazole Business (2019-2024)
11.12.5 Union-Bio science Recent Development
11.13 Brilliant Pharmaceuticals
11.13.1 Brilliant Pharmaceuticals Company Details
11.13.2 Brilliant Pharmaceuticals Business Overview
11.13.3 Brilliant Pharmaceuticals Oral Voriconazole Introduction
11.13.4 Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
11.13.5 Brilliant Pharmaceuticals Recent Development
11.14 Zhuhai Rundu Pharmaceutical
11.14.1 Zhuhai Rundu Pharmaceutical Company Details
11.14.2 Zhuhai Rundu Pharmaceutical Business Overview
11.14.3 Zhuhai Rundu Pharmaceutical Oral Voriconazole Introduction
11.14.4 Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
11.14.5 Zhuhai Rundu Pharmaceutical Recent Development
11.15 Poly Pharm
11.15.1 Poly Pharm Company Details
11.15.2 Poly Pharm Business Overview
11.15.3 Poly Pharm Oral Voriconazole Introduction
11.15.4 Poly Pharm Revenue in Oral Voriconazole Business (2019-2024)
11.15.5 Poly Pharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Sandoz Inc
Sun Pharmaceutical
TEVA
Taj Pharmaceuticals
SiNi Pharma
Lupin Pharmaceuticals
Viona Pharmaceuticals
Yangzijiang Pharmaceutical Group
Huahai Pharmaceutical
Brilliant Pharmaceuticals
Zhuhai Rundu Pharmaceutical
Poly Pharm
Beijing Genetech Pharmaceutical
Union-Bio science
List of Tables
 Table 1. Global Oral Voriconazole Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Voriconazole Tablets
 Table 3. Key Players of Voriconazole Capsules
 Table 4. Key Players of Voriconazole Suspension
 Table 5. Global Oral Voriconazole Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Oral Voriconazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Oral Voriconazole Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Oral Voriconazole Market Share by Region (2019-2024)
 Table 9. Global Oral Voriconazole Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Oral Voriconazole Market Share by Region (2025-2030)
 Table 11. Oral Voriconazole Market Trends
 Table 12. Oral Voriconazole Market Drivers
 Table 13. Oral Voriconazole Market Challenges
 Table 14. Oral Voriconazole Market Restraints
 Table 15. Global Oral Voriconazole Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Oral Voriconazole Market Share by Players (2019-2024)
 Table 17. Global Top Oral Voriconazole Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Voriconazole as of 2023)
 Table 18. Ranking of Global Top Oral Voriconazole Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Oral Voriconazole Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Oral Voriconazole, Headquarters and Area Served
 Table 21. Global Key Players of Oral Voriconazole, Product and Application
 Table 22. Global Key Players of Oral Voriconazole, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Oral Voriconazole Revenue Market Share by Type (2019-2024)
 Table 26. Global Oral Voriconazole Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Oral Voriconazole Revenue Market Share by Type (2025-2030)
 Table 28. Global Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Oral Voriconazole Revenue Market Share by Application (2019-2024)
 Table 30. Global Oral Voriconazole Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Oral Voriconazole Revenue Market Share by Application (2025-2030)
 Table 32. North America Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Oral Voriconazole Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Oral Voriconazole Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Pfizer Company Details
 Table 48. Pfizer Business Overview
 Table 49. Pfizer Oral Voriconazole Product
 Table 50. Pfizer Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 51. Pfizer Recent Development
 Table 52. Sandoz Company Details
 Table 53. Sandoz Business Overview
 Table 54. Sandoz Oral Voriconazole Product
 Table 55. Sandoz Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 56. Sandoz Recent Development
 Table 57. Sun Pharmaceutical Company Details
 Table 58. Sun Pharmaceutical Business Overview
 Table 59. Sun Pharmaceutical Oral Voriconazole Product
 Table 60. Sun Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 61. Sun Pharmaceutical Recent Development
 Table 62. Teva Company Details
 Table 63. Teva Business Overview
 Table 64. Teva Oral Voriconazole Product
 Table 65. Teva Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 66. Teva Recent Development
 Table 67. Taj Pharmaceuticals Company Details
 Table 68. Taj Pharmaceuticals Business Overview
 Table 69. Taj Pharmaceuticals Oral Voriconazole Product
 Table 70. Taj Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 71. Taj Pharmaceuticals Recent Development
 Table 72. SiNi Pharma Company Details
 Table 73. SiNi Pharma Business Overview
 Table 74. SiNi Pharma Oral Voriconazole Product
 Table 75. SiNi Pharma Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 76. SiNi Pharma Recent Development
 Table 77. Lupin Pharmaceuticals Company Details
 Table 78. Lupin Pharmaceuticals Business Overview
 Table 79. Lupin Pharmaceuticals Oral Voriconazole Product
 Table 80. Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 81. Lupin Pharmaceuticals Recent Development
 Table 82. Viona Pharmaceuticals Company Details
 Table 83. Viona Pharmaceuticals Business Overview
 Table 84. Viona Pharmaceuticals Oral Voriconazole Product
 Table 85. Viona Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 86. Viona Pharmaceuticals Recent Development
 Table 87. Yangzijiang Pharmaceutical Group Company Details
 Table 88. Yangzijiang Pharmaceutical Group Business Overview
 Table 89. Yangzijiang Pharmaceutical Group Oral Voriconazole Product
 Table 90. Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 91. Yangzijiang Pharmaceutical Group Recent Development
 Table 92. Huahai Pharmaceutical Company Details
 Table 93. Huahai Pharmaceutical Business Overview
 Table 94. Huahai Pharmaceutical Oral Voriconazole Product
 Table 95. Huahai Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 96. Huahai Pharmaceutical Recent Development
 Table 97. Beijing Genetech Pharmaceutical Company Details
 Table 98. Beijing Genetech Pharmaceutical Business Overview
 Table 99. Beijing Genetech Pharmaceutical Oral Voriconazole Product
 Table 100. Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 101. Beijing Genetech Pharmaceutical Recent Development
 Table 102. Union-Bio science Company Details
 Table 103. Union-Bio science Business Overview
 Table 104. Union-Bio science Oral Voriconazole Product
 Table 105. Union-Bio science Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 106. Union-Bio science Recent Development
 Table 107. Brilliant Pharmaceuticals Company Details
 Table 108. Brilliant Pharmaceuticals Business Overview
 Table 109. Brilliant Pharmaceuticals Oral Voriconazole Product
 Table 110. Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 111. Brilliant Pharmaceuticals Recent Development
 Table 112. Zhuhai Rundu Pharmaceutical Company Details
 Table 113. Zhuhai Rundu Pharmaceutical Business Overview
 Table 114. Zhuhai Rundu Pharmaceutical Oral Voriconazole Product
 Table 115. Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 116. Zhuhai Rundu Pharmaceutical Recent Development
 Table 117. Poly Pharm Company Details
 Table 118. Poly Pharm Business Overview
 Table 119. Poly Pharm Oral Voriconazole Product
 Table 120. Poly Pharm Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)
 Table 121. Poly Pharm Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Oral Voriconazole Picture
 Figure 2. Global Oral Voriconazole Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oral Voriconazole Market Share by Type: 2023 VS 2030
 Figure 4. Voriconazole Tablets Features
 Figure 5. Voriconazole Capsules Features
 Figure 6. Voriconazole Suspension Features
 Figure 7. Global Oral Voriconazole Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Oral Voriconazole Market Share by Application: 2023 VS 2030
 Figure 9. Hospital Pharmacy Case Studies
 Figure 10. Retail Pharmacy Case Studies
 Figure 11. Oral Voriconazole Report Years Considered
 Figure 12. Global Oral Voriconazole Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Oral Voriconazole Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Oral Voriconazole Market Share by Region: 2023 VS 2030
 Figure 15. Global Oral Voriconazole Market Share by Players in 2023
 Figure 16. Global Top Oral Voriconazole Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Voriconazole as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Oral Voriconazole Revenue in 2023
 Figure 18. North America Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Oral Voriconazole Market Share by Country (2019-2030)
 Figure 20. United States Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Oral Voriconazole Market Share by Country (2019-2030)
 Figure 24. Germany Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Oral Voriconazole Market Share by Region (2019-2030)
 Figure 32. China Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Oral Voriconazole Market Share by Country (2019-2030)
 Figure 40. Mexico Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Oral Voriconazole Market Share by Country (2019-2030)
 Figure 44. Turkey Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Pfizer Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 48. Sandoz Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 49. Sun Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 50. Teva Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 51. Taj Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 52. SiNi Pharma Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 53. Lupin Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 54. Viona Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 55. Yangzijiang Pharmaceutical Group Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 56. Huahai Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 57. Beijing Genetech Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 58. Union-Bio science Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 59. Brilliant Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 60. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 61. Poly Pharm Revenue Growth Rate in Oral Voriconazole Business (2019-2024)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Voriconazole Vfend Market Research Report 2024
Global Itraconazole Oral Solution Market Research Report 2024
Global Fenticonazole Market Research Report 2024
Voriconazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Voriconazole Market Research Report 2025
Voriconazole Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Itraconazole Market Research Report 2024
Voriconazole for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Voriconazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fluconazole Preparation Market Research Report 2024
Global Ketoconazole API Market Research Report 2024
Global Ketoconazole Market Insights Forecast to 2030
Fluconazole Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antifungal Drugs for Skin Market Research Report 2024
Vaginal Fungi Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Itraconazole Solutions Market Research Report 2024
Itraconazole Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nystatin Tablets Market Research Report 2024
Fluconazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Azole Antifungals Market Research Report 2024

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions